US › Healthcare

Hyperion DeFi, Inc. (HYPD)

US · Healthcare · Biotechnology

$2.49-2.73%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$357,693

Net profit

$31.0M

EPS

$0.92

EPS estimate

$2.24

Net margin

8,652.9%

EPS came in at 0.92 against a street estimate of 2.24 — a miss of 58.9%.

Key statistics

Market cap

$38.9M

Forward P/E

0.0

P/B

0.45

Book value

$6.66

EPS (TTM)

$-6.46

52-week high

$6.30

52-week low

$2.34

50-day MA

$3.41

200-day MA

$3.36

Beta

2.74

Analyst view

Analysts rate Hyperion DeFi, Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $9.82.

Shareholding

Insiders

5.33%

Institutions

18.91%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	3.07%
Franklin Templeton Inc	2.60%
Arrington Capital Management, LLC	1.96%
Morgan Stanley - Brokerage Accounts	1.57%
Almanack Investment Partners, LLC.	1.11%
Geode Capital Management, LLC	0.86%
Jane Street Group LLC	0.84%
Oppenheimer & Co Inc	0.83%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hyperion DeFi, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.